These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 24109224)

  • 1. The Fc region of an antibody impacts the neutralization of West Nile viruses in different maturation states.
    Lee PD; Mukherjee S; Edeling MA; Dowd KA; Austin SK; Manhart CJ; Diamond MS; Fremont DH; Pierson TC
    J Virol; 2013 Dec; 87(24):13729-40. PubMed ID: 24109224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maturation of West Nile virus modulates sensitivity to antibody-mediated neutralization.
    Nelson S; Jost CA; Xu Q; Ess J; Martin JE; Oliphant T; Whitehead SS; Durbin AP; Graham BS; Diamond MS; Pierson TC
    PLoS Pathog; 2008 May; 4(5):e1000060. PubMed ID: 18464894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined effects of the structural heterogeneity and dynamics of flaviviruses on antibody recognition.
    Dowd KA; Mukherjee S; Kuhn RJ; Pierson TC
    J Virol; 2014 Oct; 88(20):11726-37. PubMed ID: 25078693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunodominance and functional activities of antibody responses to inactivated West Nile virus and recombinant subunit vaccines in mice.
    Zlatkovic J; Stiasny K; Heinz FX
    J Virol; 2011 Mar; 85(5):1994-2003. PubMed ID: 21147919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dynamic landscape for antibody binding modulates antibody-mediated neutralization of West Nile virus.
    Dowd KA; Jost CA; Durbin AP; Whitehead SS; Pierson TC
    PLoS Pathog; 2011 Jun; 7(6):e1002111. PubMed ID: 21738473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis of West Nile virus neutralization by a therapeutic antibody.
    Nybakken GE; Oliphant T; Johnson S; Burke S; Diamond MS; Fremont DH
    Nature; 2005 Sep; 437(7059):764-9. PubMed ID: 16193056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A protective human monoclonal antibody targeting the West Nile virus E protein preferentially recognizes mature virions.
    Goo L; Debbink K; Kose N; Sapparapu G; Doyle MP; Wessel AW; Richner JM; Burgomaster KE; Larman BC; Dowd KA; Diamond MS; Crowe JE; Pierson TC
    Nat Microbiol; 2019 Jan; 4(1):71-77. PubMed ID: 30455471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.
    Lai H; Paul AM; Sun H; He J; Yang M; Bai F; Chen Q
    Vaccine; 2018 Mar; 36(14):1846-1852. PubMed ID: 29490880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recovery of West Nile Virus Envelope Protein Domain III Chimeras with Altered Antigenicity and Mouse Virulence.
    McAuley AJ; Torres M; Plante JA; Huang CY; Bente DA; Beasley DWC
    J Virol; 2016 May; 90(9):4757-4770. PubMed ID: 26912625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human monoclonal antibodies against West Nile virus induced by natural infection neutralize at a postattachment step.
    Vogt MR; Moesker B; Goudsmit J; Jongeneelen M; Austin SK; Oliphant T; Nelson S; Pierson TC; Wilschut J; Throsby M; Diamond MS
    J Virol; 2009 Jul; 83(13):6494-507. PubMed ID: 19386704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular basis of antibody-mediated neutralization of West Nile virus.
    Oliphant T; Diamond MS
    Expert Opin Biol Ther; 2007 Jun; 7(6):885-92. PubMed ID: 17555373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of anti-DIII antibodies by the C3d derivative P28 results in lower viral titers and augments protection in mice.
    Dunn MD; Rossi SL; Carter DM; Vogt MR; Mehlhop E; Diamond MS; Ross TM
    Virol J; 2010 May; 7():95. PubMed ID: 20462412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies against the envelope glycoprotein promote infectivity of immature dengue virus serotype 2.
    da Silva Voorham JM; Rodenhuis-Zybert IA; Ayala Nuñez NV; Colpitts TM; van der Ende-Metselaar H; Fikrig E; Diamond MS; Wilschut J; Smit JM
    PLoS One; 2012; 7(3):e29957. PubMed ID: 22431958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection.
    Pierson TC; Sánchez MD; Puffer BA; Ahmed AA; Geiss BJ; Valentine LE; Altamura LA; Diamond MS; Doms RW
    Virology; 2006 Mar; 346(1):53-65. PubMed ID: 16325883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody recognition and neutralization determinants on domains I and II of West Nile Virus envelope protein.
    Oliphant T; Nybakken GE; Engle M; Xu Q; Nelson CA; Sukupolvi-Petty S; Marri A; Lachmi BE; Olshevsky U; Fremont DH; Pierson TC; Diamond MS
    J Virol; 2006 Dec; 80(24):12149-59. PubMed ID: 17035317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The structural immunology of antibody protection against West Nile virus.
    Diamond MS; Pierson TC; Fremont DH
    Immunol Rev; 2008 Oct; 225():212-25. PubMed ID: 18837784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes.
    Sukupolvi-Petty S; Austin SK; Purtha WE; Oliphant T; Nybakken GE; Schlesinger JJ; Roehrig JT; Gromowski GD; Barrett AD; Fremont DH; Diamond MS
    J Virol; 2007 Dec; 81(23):12816-26. PubMed ID: 17881453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection.
    Pierson TC; Xu Q; Nelson S; Oliphant T; Nybakken GE; Fremont DH; Diamond MS
    Cell Host Microbe; 2007 Apr; 1(2):135-45. PubMed ID: 18005691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single mutation in the envelope protein modulates flavivirus antigenicity, stability, and pathogenesis.
    Goo L; VanBlargan LA; Dowd KA; Diamond MS; Pierson TC
    PLoS Pathog; 2017 Feb; 13(2):e1006178. PubMed ID: 28207910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A monoclonal antibody to DIII E protein allowing the differentiation of West Nile virus from other flaviviruses by a lateral flow assay.
    Rebollo B; Pérez T; Camuñas A; Pérez-Ramírez E; Llorente F; Sánchez-Seco MP; Jiménez-Clavero MÁ; Venteo Á
    J Virol Methods; 2018 Oct; 260():41-44. PubMed ID: 29958922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.